• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

kate.burbury@unimelb.edu.au

Credentials


Position
Clinical (Associate Professor)
The Sir Peter MacCallum Department of Oncology

A/Prof Kate Burbury

Clinical (Associate Professor)
The Sir Peter MacCallum Department of Oncology

192 Scholarly works
4 Projects

HIGHLIGHTS

  • 2026

    Journal article

    Venetoclax and ibrutinib induces durable clinical responses in marginal zone lymphoma
    DOI: 10.1182/bloodadvances.2025016646
  • 2026

    Journal article

    Long-term survival outcomes after biomarker-guided thromboprophylaxis in cancer: extended follow-up of the TARGET-TP randomised trial.
    DOI: 10.1093/jnci/djag065
  • 2026

    Journal article

    Implementing Teletrials to Improve Equity of Access for Regional Patients With Cancer: Report From the Victorian Teletrial Collaborative
    DOI: 10.1111/ajco.14209
  • 2024

    Research grants (other domestic)

    Artificial Intelligence Based Surgical Risk Calculator for Cancer Surgery: The ANCHOR Project \2013 Phase 2.
  • 2024

    Research grants (ARC, NHMRC, MRFF)

    Defining the Structure-Activity Relationship of a Targetable Neoepitope to Improve Outcomes in CALR+ Myelofibrosis
  • 2023

    Research grants (other domestic)

    The ISIAH Study
  • 2018

    Journal article

    Ibrutinib plus venetoclax for the treatment of mantle-cell lymphoma
    DOI: 10.1056/NEJMoa1715519
Kate Burbury

RECENT SCHOLARLY WORKS

  • 2026

    Journal article

    Ultraprecision therapy for type 1 vs type 2 CALR MPN by dual epitope targeting that restores ruxolitinib sensitivity
    DOI: 10.1182/blood.2024027897
  • 2026

    Journal article

    Usability and Acceptance Testing of an Electronic Patient-Reported Outcome Symptom Monitoring System for People Receiving Immune Checkpoint Inhibitors: Mixed Methods Study
    DOI: 10.2196/79694
  • 2025

    Journal article

    Teletrial implementation in early phase clinical trials: two national workshops
    DOI: 10.1186/s13063-025-08804-y
  • 2025

    Journal article

    ADORE: an open platform study of ruxolitinib in combination with other novel therapies in patients with myelofibrosis
    DOI: 10.1182/bloodadvances.2025015860
  • 2025

    Journal article

    Customizing workflows for electronic patient-reported outcome (ePRO) symptom monitoring using the action, actor, context, target, time (AACTT) framework
    DOI: 10.1007/s11136-025-03995-y
  • 2025

    Journal article

    Associations between non-anaemic iron deficiency and outcomes following elective surgery for colorectal cancer: a prospective cohort study*
    DOI: 10.1111/anae.16444
  • 2025

    Journal article

    Digital Solution to Support Medication Adherence and Self-Management in Patients with Cancer (SAMSON): Pilot Randomized Controlled Trial
    DOI: 10.2196/65302

RECENT PROJECTS

  • 2026

    Research grants (ARC, NHMRC, MRFF)

    Implementing Enhanced Recovery After Surgery (ERAS) With Prehabilitation (ERAS+) in Routine Practice: Strategies to Optimise Surgical Care and Improve Outcomes Through ERAS+.

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia


View all Campus locations  
facebookIconlinkedinIconinstagramIcontwitterIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224